Heated Dispute Over 'Safer' Cigarette

The promise of a “safer” cigarette may have been dampened today with findings that the smoke-free “Eclipse” contains higher levels of cancerous toxins than other low-tar brands already on the market.

Several anti-tobacco groups, including the Campaign for Tobacco-Free Kids, the American Heart Association and the Massachusetts Department of Public Health, released the results of the study today at a press conference in Washington, D.C. An independent laboratory, Labstat International of Ontario, Canada, performed the analysis with funding from the state health agency.

In response to the results, the Massachusetts health department contacted the Food and Drug Administration, the Federal Trade Commission and the Massachusetts Attorney General asking them to investigate the safety claims being made by R.J. Reynolds Tobacco Co. of Winston-Salem, N.C. on its Web site and in ads.

One claim, for example, the firm makes is that Eclipse may present less risk of cancer compared to other cigarettes.

The groups hope this report will spark an immediate governmental review of the product and its removal from the marketplace. “We want to see independent regulatory bodies review the scientific research in a comprehensive way,” says Dr. Greg Connolly, director of the Massachusetts Tobacco Control Project, who initiated the research.

A Safer Ciggie? R.J. Reynolds developed the Eclipse cigarette to help reduce the health hazards of smoking. Rather than burning the tobacco directly, the Eclipse heats the tobacco using a carbon rod insulated by glass fibers. The smoker inhales the heated air drawn across the tobacco.

Because only 3 percent of the tobacco is actually burned, the manufacturer says the cigarette produces fewer cancer-causing chemicals. It also produces very little second-hand smoke, potentially reducing the growing conflict between smokers and non-smokers.

The Eclipse was developed under the name Premier in 1988. It was test-marketed in Chattanooga, Tenn., in 1996. Currently, it is being tested in the Dallas-Ft. Worth area, and is also available for purchase via phone or internet.

R.J. Reynolds began specifically touting the cigarette as safer for smokers this past spring, after its researchers reported that the Eclipse produced around 80 percent less carcinogens and tar in its smoke than a traditional ultra-light brand of cigarette, the “Merit Ultralight.”

The company began contending the cigarette was less likely to cause a risk of cancer, bronchitis or possibly emphysema, with ads saying: “A cigarette that responds to concerns about certain smoking-related illnesses. Including cancer.”

Claims Challenged Questioning those claims, the Massachusetts Tobacco Control Project commissioned a Canadian laboratory to investigate the cigarette, comparing the Eclipse to two other low-tar brands, RJR Reynold’s own “Now King Size Hard Pack,” and Brown & Williamson’s “Carlton King Size Soft Pack.”

The results, released today, say Eclipse had equivalent amounts of nicotine and higher amounts of known cancer-causing chemicals than the other products: The Eclipse contained 734 percent more acetaldehyde and 475 percent more acrolein, two carcinogens, than the Now cigarette.

The lab also detected higher toxin levels than when the product was originally released in 1996.

  • 1
  • |
  • 2
Join the Discussion
blog comments powered by Disqus
You Might Also Like...